Credit Suisse Boosts Price Target, Estimates on DR Horton (DHI)
According to analysts at Credit Suisse, DR Horton Inc. (DHI) will see higher sales going forward, which should lead to margin expansion. As such, the analysts raised the price target and earnings estimates through 2014 on the home builder.
The analysts maintain an “Outperform” rating on DHI and now see shares reaching $28. This new valuation suggests a 5% upside to Friday’s closing price of $26.66.
DR Horton shares were up 34 cents, or +1.28%, during pre-market trading on Monday. The stock is up +30.75% year-to-date.
The Bottom Line
Shares of DR Horton (DHI) have a dividend yield of 2.25% based on Friday’s closing price of $26.66 and the company’s annualized dividend payout of 60 cents per share.
DR Horton Inc. (DHI) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.2 out of 5 stars.
Get FREE Dividend Tips, Updates & MoreWe respect your privacy
- Powerful dividend insights sent every weekday morning
- Gain instant access to actionable investing tips
- Strategically grow your portfolio’s profitability